In vitro evaluation of S-(+)-ibuprofen as drug candidate for intra-articular drug delivery system

Drug Development and Industrial Pharmacy

Volumn 41, Issue 1, 2015, Pages 85-94

  Bédouet, Laurent ^a   Pascale, Florentina ^b   Bonneau, Michel ^b   Laurent, Alexandre ^a,b,c  

^a Occlugel SAS   (France)

^b ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^c HÔPITAL LARIBOISIÈRE   (France)

Author keywords

Cartilage; Co culture; Drug delivery systems; Osteoarthritis; S (+) ibuprofen

Indexed keywords

AMYLOID PROTEIN; IBUPROFEN; LIPOPOLYSACCHARIDE; NITRIC OXIDE; PROSTAGLANDIN; PROSTAGLANDIN SYNTHASE; PROTEOGLYCAN; NONSTEROID ANTIINFLAMMATORY AGENT;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CARTILAGE; CARTILAGE DEGENERATION; COCULTURE; CONTROLLED STUDY; CYTOLYSIS; DRUG DELIVERY SYSTEM; DRUG EFFICACY; ENZYME INHIBITION; EXPLANT; IN VITRO STUDY; INTRAARTICULAR DRUG DELIVERY SYSTEM; JOINT CAPSULE; NONHUMAN; PROTEIN DEGRADATION; SHEEP; SHOULDER; SYNOVIUM; SYNTHESIS; TISSUE CULTURE; ANIMAL; CHEMISTRY; DRUG EFFECTS; DRUG SCREENING; INTRAARTICULAR DRUG ADMINISTRATION; METABOLISM; PROCEDURES;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; COCULTURE TECHNIQUES; DRUG DELIVERY SYSTEMS; DRUG EVALUATION, PRECLINICAL; IBUPROFEN; INJECTIONS, INTRA-ARTICULAR; SHEEP; SYNOVIAL MEMBRANE;

EID: 84918771721     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.3109/03639045.2013.850704     Document Type: Article

References (53)

1. Boureau F, Schneid H, Zeghari N, et al. The IPSO study: ibuprofen, paracetamol study in osteoarthritis. A randomised comparative clinical study comparing the efficacy and safety of ibuprofen and paracetamol analgesic treatment of osteoarthritis of the knee or hip. Ann Rheum Dis 2004;63:1028-34.
2. Vane JR. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nature 1971;231:232-5.
3. Martel-Pelletier J, Pelletier JP, Fahmi H. Cyclooxygenase-2 and prostaglandins in articular tissues. Semin Arthritis Rheum 2003;33: 155-67.
4. Notoya K, Jovanovic DV, Reboul P, et al. The induction of cell death in human osteoarthritis chondrocytes by nitric oxide is related to the production of prostaglandin E2 via the induction of cyclooxygenase-2. J Immunol 2000;165:3402-10.
5. Alvarez-Soria MA, Largo R, Santillana J, et al. Long term NSAID treatment inhibits COX-2 synthesis in the knee synovial membrane of patients with osteoarthritis: differential proinflammatory cytokine profile between celecoxib and aceclofenac. Ann Rheum Dis 2006; 65:998-1005.
6. Caviglioli G, Valeria P, Brunella P, et al. Identification of degradation products of ibuprofen arising from oxidative and thermal treatments. J Pharm Biomed Anal 2002;15:499-509.
7. Moore N. Ibuprofen: a journey from prescription to over-the-counter use. J R Soc Med 2007;100(Suppl. 48):2-6.
8. Sanchez C, Mateus MM, Defresne MP, et al. Metabolism of human articular chondrocytes cultured in alginate beads. Longterm effects of interleukin 1beta and nonsteroidal antiinflammatory drugs. J Rheumatol 2002;29:772-82.
9. Mukherjee P, Rachita C, Aisen PS, Pasinetti GM. Non-steroidal antiinflammatory drugs protect against chondrocyte apoptotic death. Clin Exp Rheumatol 2001;19:S7-11.
10. Arsenis C, McDonnell J. Effects of antirheumatic drugs on the interleukin-1 alpha induced synthesis and activation of proteinases in articular cartilage explants in culture. Agents Actions 1989;27: 261-4.
11. Manicourt DH, Bevilacqua M, Righini V, et al. Comparative effect of nimesulide and ibuprofen on the urinary levels of collagen type II C-telopeptide degradation products and on the serum levels of hyaluronan and matrix metalloproteinases-3 and-13 in patients with flare-up of osteoarthritis. Drugs RD 2005;6:261-71.
12. Gineyts E, Mo JA, Ko A, et al. Effects of S-(+)-ibuprofen on molecular markers of cartilage and synovium turnover in patients with knee osteoarthritis. Ann Rheum Dis 2004;63:857-61.
13. Adatia A, Rainsford KD, Kean WF. Osteoarthritis of the knee and hip. Part II: therapy with ibuprofen and a review of clinical trials. J Pharm Pharmacol 2012;64:626-36.
14. Driban JB, Barr AE, Amin M, et al. Joint inflammation and early degeneration induced by high-force reaching are attenuated by ibuprofen in an animal model of work-related musculoskeletal disorder. J Biomed Biotechnol 2011;2011:Article ID 691412. DOI: 10.1155/2011/691412.
15. Fung HB, Kirschenbaum HL. Selective cyclooxygenase-2 inhibitors for the treatment of arthritis. Clin Ther 1999;21:1131-57.
16. Reijman M, Bierma-Zeinstra SM, Pols HA, et al. Is there an association between the use of different types of nonsteroidal antiinflammatory drugs and radiologic progression of osteoarthritis? The Rotterdam Study. Arthritis Rheum 2005;52:3137-42.
17. Larsen C, Ostergaard J, Larsen SW, et al. Intra-articular depot formulation principles: role in the management of postoperative pain and arthritic disorders. Int J Pharm 2008;97:4622-54.
18. Thompson CJ, Hansford D, Munday DL, et al. Synthesis and evaluation of novel polyester-ibuprofen conjugates for modified drug release. Drug Dev Ind Pharm 2008;34:877-84.
19. Shin BK, Baek EJ, Choi SG, et al. Preparation and irradiation of Pluronic F127-based thermoreversible and mucoadhesive hydrogel for local delivery of naproxen. Drug Dev Ind Pharm 2012. [Epub ahead of print]. DOI: 10.3109/036399045.2012.665925.
20. Oliveira RB, Nascimento TL, Lima EM. Design and characterization of sustained release ketoprofen entrapped carnauba wax micro-particles. Drug Dev Ind Pharm 2012;38:1-11.
21. Adams SS, Bresloff P, Mason CG Pharmacological differences between the optical isomers of ibuprofen: evidence for metabolic inversion of the (-)-isomer. J Pharm Pharmacol 1976;28:256-7.
22. Stock KP, Geisslinger G, Loew D, et al. S-ibuprofen versus ibuprofen-racemate. A randomized double-blind study in patients with rheumatoid arthritis. Rheumatol Int 1991;11:199-202.
23. Hawel R, Klein G, Singer F, et al. Comparison of the efficacy and tolerability of dexibuprofen and celecoxib in the treatment of osteoarthritis of the hip. Int J Clin Pharmacol Ther 2003;41: 153-64.
24. Panico AM, Cardile V, Gentile B, et al. "In vitro" differences among (R) and (S) enantiomers of profens in their activities related to articular pathophysiology. Inflammation 2005;29:119-28.
25. Armstrong S, Lees P. Effects of R and S enantiomers and a racemic mixture of carprofen on the production and release of proteoglycan and prostaglandin E2 from equine chondrocytes and cartilage explants. Am J Vet Res 1999;60:98-104.
26. Armstrong S, Lees P. Effects of carprofen (R and S enantiomers and racemate) on the production of IL-1, IL-6 and TNF-a by equine chondrocytes and synoviocytes. J Vet Pharmacol Ther 2002;25: 145-53.
27. Bédouet L, Pascale F, Bonneau M, et al. In vitro evaluation of (S)-ibuprofen toxicity on joint cells and explants of cartilage and synovial membrane. Toxicol In Vitro 2011;25:1944-52.
28. Mitchell JA, Akarasereenont P, Thiemermann C, et al. Selectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase. Proc Natl Acad Sci USA 1993;90: 11693-7.
29. Netter P, Bannwarth B, Royer-Morrot MJ. Recent findings on the pharmacokinetics of non-steroidal anti-inflammatory drugs in synovial fluid. Clin Pharmacokinet 1989;17:145-62.
30. Tegeder I, Pfeilschifter J, Geisslinger G. Cyclooxygenase-independ-ent actions of cyclooxygenase inhibitors. FASEB J 2001;15: 2057-72.
31. Yoon JB, Kim SJ, Hwang SG, et al. Non-steroidal anti-inflammatory drugs inhibit nitric oxide-induced apoptosis and dedifferentiation of articular chondrocytes independent of cyclooxygenase activity. J Biol Chem 2003;278:15319-25.
32. Fell HB, Jubb RW. The effect of synovial tissue on the breakdown of articular cartilage in organ culture. Arthritis Rheum 1977;20: 1359-71.
33. Lee JH, Fitzgerald JB, DiMicco MA, et al. Co-culture of mechanically injured cartilage with joint capsule tissue alters chondrocyte expression patterns and increases ADAMTS5 production. Arch Biochem Biophys 2009;489:118-26.
34. Patwari P, Lin SN, Kurz B, et al. Potent inhibition of cartilage biosynthesis by coincubation with joint capsule through an IL-1-independent pathway. Scand J Med Sci Sports 2009;19:528-35.
35. Levis KA, Lane MA, Corrigan OI. Effect of buffer media composition on the solubility and effective permeability coefficient of ibuprofen. Int J Pharm 2003;253:49-59.
36. Farndale RW, Buttle DJ, Barrett AJ. Improved quantitation and discrimination of sulphated glycosaminoglycans by use of dimethylmethylene blue. Biochim Biophys Acta 1986;883: 173-7.
37. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970;227:680-5.
38. Tunçay M, Calis S, Kas HS, et al. Diclofenac sodium incorporated PLGA (50:50) microspheres: formulation considerations and in vitro/in vivo evaluation. Int J Pharm 2000;195:179-88.
39. Bozdag S, Calis S, Kas HS, et al. In vitro evaluation and intra-articular administration of biodegradable microspheres containing naproxen sodium. J Microencapsul 2001;18:443-56.
40. Lu Y, Zhang G, Sun D, Zhong Y. Preparation and evaluation of biodegradable flurbiprofen gelatin micro-spheres for intra-articular administration. J Microencapsul 2007;24:515-24.
41. Thakkar H, Sharma RK, Mishra AK, et al. Albumin microspheres as carriers for the antiarthritic drug celecoxib. AAPS PharmSciTech 2005;6:65-73.
42. Fernández-Carballido A, Herrero-Vanrell R, Molina-Martinez IT, Pastoriza P. Biodegradable ibuprofen-loaded PLGA microspheres for intraarticular administration. Effect of Labrafil addition on release in vitro. Int J Pharm 2004;279:33-41.
43. Stratman NC, Carter DB, Sethy VH. Ibuprofen: effect on inducible nitric oxide synthase. Brain. Res. Mol. Brain. Res 1997;50:107-12.
44. Abramson SB. Nitric oxide in inflammation and pain associated with osteoarthritis. Arthritis Res Ther 2008;10:S2.
45. Stevens AL, Wheeler CA, Tannenbaum SR, Grodzinsky AJ. Nitric oxide enhances aggrecan degradation by aggrecanase in response to TNF-alpha but not IL-1beta treatment at a post-transcriptional level in bovine cartilage explants. Osteoarthritis Cartilage 2008;16: 489-97.
46. Fenton JI, Chlebek-Brown KA, Peters TL, et al. Glucosamine HCl reduces equine articular cartilage degradation in explant culture. Osteoarthritis Cartilage 2000;8:258-65.
47. Haglund L, Bernier SM, Onnerfjord P, Recklies AD. Proteomic analysis of the LPS-induced stress response in rat chondrocytes reveals induction of innate immune response components in articular cartilage. Matrix Biol 2008;27:107-18.
48. Jacobsen S, Niewold TA, Halling-Thomsen M, et al. Serum amyloid A isoforms in serum and synovial fluid in horses with lipopolysac-charide-induced arthritis. Vet Immunol Immunopathol 2006;110: 325-30.
49. Migita K, Koga T, Torigoshi T, et al. Serum amyloid A protein stimulates CCL20 production in rheumatoid synoviocytes. Rheumatology 2009;48:741-7.
50. Stuhlmeier KM, Li H, Kao JJ. Ibuprofen: new explanation for an old phenomenon. Biochem Pharmacol 1999;57:313-20.
51. Greenberg DD, Stoker A, Kane S, et al. Biochemical effects of two different hyaluronic acid products in a co-culture model of osteoarthritis. Osteoarthritis Cartilage 2006;14:814-22.
52. Ibold Y, Frauenschuh S, Kaps C, et al. Development of a high-throughput screening assay based on the 3-dimensional pannus model for rheumatoid arthritis. J Biomol Screen 2007;12:956-65.
53. Hardy MM, Seibert K, Manning PT, et al. Cyclooxygenase 2-dependent prostaglandin E2 modulates cartilage proteoglycan degradation in human osteoarthritis explants. Arthritis Rheum 2002;46: 1789-803.